Results

Total Results: 351 records

Showing results for "oral health screening tools".

  1. effectivehealthcare.ahrq.gov/sites/default/files/pdf/chronic-kidney-disease-anemia-2011_research-protocol.pdf
    January 01, 2011 - Concentrations of Hb in nondialysis-dependent CKD patients who have anemia can be improved with oral … patients (who may or may not be receiving ESA treatment), intravenous iron therapy is preferred over oral … care, and others with experience in making health care decisions. … August 29, 2011 17 35 exp Predictive Value of Tests/ 107,715 36 exp ROC CURVE/ 18,819 37 exp MassScreening/ 84,398 38 exp diagnosis/ 5,287,805 39 exp REPRODUCIBILITY OF RESULTS/ 208,459 40 exp
  2. effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
    March 01, 2012 - factor Xa inhibitors, injectable or oral direct thrombin inhibitors [DTIs], oral vitamin K antagonists … Classes include oral antiplatelet agents, injectable LMWHs, injectable UFH, injectable or oral factor … Xa inhibitors, injectable or oral DTIs, oral VKAs, and mechanical interventions. … Additionally, most trials evaluated intermediate health outcomes and did not address final health outcomes … In a controlled observational study, oral VKAs had significantly fewer fatal PE events versus oral
  3. effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-future-presentation-format_research.pdf
    January 01, 2019 - part, as the basis for the development of clinical practice guidelines and other quality enhancement tools … relief in sore throat: systematic review and meta-analysis 2009 BMJ 16458764 Self-monitoring of oral … - the case of screening for abdominal aortic aneurysm in Sweden 2006 Health Econ 16706572 Comprehensive … Care 16707071 The cost-effectiveness of screening for oral cancer in primary care 2006 Health Technol … economic model for breast cancer screening 2008 Value Health 18272361 Surveillance of Barrett's
  4. effectivehealthcare.ahrq.gov/sites/default/files/arthritis-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Patients had sUA levels of 6.5 mg/dL or higher at screening, were on stable allopurinol doses (≥300 … more, and at least one measurable tophus received lesinurad 200 mg or 400 mg in combination with oralHealth care delivery infrastructure and patient management: As an oral medication, lesinurad is not
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_executive.pdf
    April 01, 2013 - The symptoms of PAH can be Effective Health Care Program The Effective Health Care Program was initiated … The object is to help consumers, health care providers, and others in making informed choices among … Symptoms that are present at rest suggest advanced disease.1 Effective Health Care Effective Health … Standard therapies included supportive therapy (diuretics, oxygen, digoxin, oral anticoagulants) with … Our findings do not support any recommendations for replacing existing measurement tools to assess
  6. effectivehealthcare.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Ivacaftor tablets are indicated for oral administration, one 150 mg dose every 12 hours for patients … drug would affect current care processes and patient management by offering patients a convenient oral … Zithromax (azithromycin tablets) and (azithromycin for oral suspension) prescribing information.
  7. #14 SUBSTANCE ABUSE (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … condition, pharmacotherapy (e.g., ES-3 buprenorphine, naltrexone) is already available in oral … The toolkit contains pain management guidelines, opioid risk-assessment tools, precautions for opioid … identified by the physician as a naloxone priority patient (according to the opioid risk- assessment tools
  8. effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-protocol-acute-pain-treatments.pdf
    August 08, 2019 - patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … patient education; (3) clinician and patient values and preferences related to opioids; (4) urine drug screening … prescription drug monitoring program data; (6) availability of close followup Nonopioid therapy: Oral … Non-prescription (OTC) oral analgesics for acute pain - an overview of Cochrane reviews. … US Department of Health and Human Services Office of the Assistant Secretary for Health.
  9. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1412.pdf
    January 01, 2015 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … EASD 2011: the next- generation of diabetes management tools. [internet]. … http://www.clinica.co.uk/marketsector/ivds/EAS D-2011-The-next-generation-of-diabetes- management-tools … Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
  10. CARDIOVASCULAR (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/cardiovascular-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Antithrombotic agents include vitamin K antagonists, aspirin, low-molecular-weight heparin, and oral … Unmet need and health outcomes: For the small population of patients with HoFH, no effective oral pharmacologic … Juxtapid (lomitapide) capsules, for oral use prescribing information.
  11. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-prevention_disposition-comments.pdf
    May 08, 2013 - reported aspiration risk (and as noted by the reviewer such patients would have been excluded from oraltools, distinguishes between screening for disease detection such as breast cancer and screening for … health education model and discusses efficacy and effectiveness of a screening program combined with … health education. … A comparison of screening for disease detection and screening for risk factors.
  12. Diabetes Mellitus (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - One health systems expert stated, “Adherence issues with oral drugs and insulin are significant.”21 … thought the MiniMed 530G has good potential to fill the unmet need for improved diabetes management tools … care delivery infrastructure, although candidates would require preliminary respiratory screening … Choice of who are the best candidates for the steroid implant may require some level of screening for … Diabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapies.
  13. effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
    December 01, 2014 - or “digital medicine,” has been developed for use with oral pill or capsule medications prescribed … Protocol interventions include screening for cognitive impairment, delirium, risk of adverse health … information with caregivers and providers, and to incorporate individualized behavior support tools … estimated 150 in development.64 Current Approach to Care Traditional EDs may incorporate cognitive screenings … (usually administered on an as-needed basis to ED patients) and other geriatric clinical tools or
  14. effectivehealthcare.ahrq.gov/sites/default/files/Evidence%20Summary_2.pdf
    May 01, 2020 - our database, and additional relevant articles not already under consideration were retrieved for screening … Articles included by either reviewer underwent full-text screening. … Of these, 915 were excluded at the full-text screening stage, leaving 167 articles for data abstraction … • Studies of these tools/methods should also explore the complexity of decision making that needs … Tools for optimizing the outcomes of labor safely.
  15. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/depression-horizon-scan-high-impact-1306.pdf
    October 01, 2014 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Mifepristone (Korlym™, Corcept Therapeutics, Inc., Menlo Park, CA) is an oral glucocorticoid-II receptor … They said the following factors would contribute to diffusion of mifepristone, if approved: its oral … implant rather than medical and talk therapy), but because it has the potential to shift care from oral
  16. #05 DEPRESSION (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/05_depression_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Mifepristone (Korlym ™ [formerly Corlux], Corcept Therapeutics, Inc., Menlo Park, CA) is an oral … Mifepristone (Korlym ™ [formerly Corlux], Corcept Therapeutics, Inc., Menlo Park, CA) is an oral … Of soldiers referred via the Post Deployment Health Assessment screening process, only 54% follow through
  17. effectivehealthcare.ahrq.gov/sites/default/files/08_functional_limitations_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … comparing oral to nasal inhalation. … Placebo- controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis. … Dihydroergotamine (migraine, Tempo-inhaled/oral), MAP. [10 p].
  18. PEPTIC ULCER #11 (pdf file)

    effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1312.pdf
    December 01, 2013 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … Treatment for severe ES-5 SBS may involve oral rehydration solutions, intravenous nutrition … Treatment for severe SBS may involve oral rehydration solutions, intravenous nutrition delivery, and … PG course: per oral endoscopic myotomy (POEM) course outline and table of contents.
  19. effectivehealthcare.ahrq.gov/sites/default/files/pdf/dietary-supplements_research-protocol.pdf
    December 15, 2010 - Reviewers will attend a screening training session, and screening forms will be pilot tested. … A broad screen of titles and abstracts will be followed by full-text screening of articles deemed relevant … Include only: ° Niacin (≤ 250 mg/d) ° Vitamins: A, D, E, K ° Vitamin D + calcium ° Magnesium (oral … Available at: http://www.igh.org/Cochrane/tools/Ch10_Reporting.pdf 3. … www.effectivehealthcare.ahrq.gov/ehc/products/60/318/Methods-Guide_Prepublication-Draft_03-2011.pdf� http://www.igh.org/Cochrane/tools
  20. effectivehealthcare.ahrq.gov/sites/default/files/01_arthritis_potential_high_impact_2012-12-10.pdf
    January 01, 2012 - Effectiveness Research, AHRQ is interested in innovations in drugs and biologics, medical devices, screening … horizon scanning, AHRQ’s interests are broad and encompass drugs, devices, procedures, treatments, screening … systems, health business, health administration, health policy). … Tofacitinib is indicated for oral administration, 5 mg twice daily. … Xeljanz (tofacitinib) tablets for oral administration prescribing information.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: